Skip to main content

Online First

Original Article

Safety of Venetoclax Without Dose Ramp-Up When Used in Combination With a Hypomethylating Agent for Acute Myeloid Leukemia

Brandon M. Gray, PharmD, BCPS; Sorana G. Ursu, PharmD, BCOP; Mohammad M. Alhousani, MD; Christina Caruso, MPAS, PA-C; Salman Fazal, MD

Original Article

The Effect of Dosing Schedule on the Incidence of Immune-Related AEs and Infusion Reactions in Patients Receiving Immunotherapy

Solmaz Karimi, PharmD, MS; April K.S. Salama, MD; Brent A. Hanks, MD, PhD; Beiyu Liu, PhD; Alaattin Erkanli, PhD; Theresa Brown, PharmD, BCOP, CPP

Results 1 - 2 of 2